Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Habermann, TM"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.
Autorzy:
Rausch Osian S; Department of Emergency Medicine and the Center for Health Equity and Quality Research, University of Florida Jacksonville , Jacksonville, FL , USA.
Leal AD
Allmer C
Maurer MJ
Nowakowski G
Inwards DJ
Macon WR
Ehlers SL
Weiner GJ
Habermann TM
Cerhan JR
Thompson CA
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2015 Feb; Vol. 56 (2), pp. 434-9. Date of Electronic Publication: 2014 Jun 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Surveys and Questionnaires*
Complementary Therapies/*statistics & numerical data
Lymphoma, Non-Hodgkin/*therapy
Survivors/*statistics & numerical data
Age Factors ; Aged ; Female ; Humans ; Male ; Middle Aged ; Sex Factors
Czasopismo naukowe
Tytuł:
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma.
Autorzy:
Yost KJ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA. />Thompson CA
Eton DT
Allmer C
Ehlers SL
Habermann TM
Shanafelt TD
Maurer MJ
Slager SL
Link BK
Cerhan JR
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Feb; Vol. 54 (2), pp. 290-7. Date of Electronic Publication: 2012 Sep 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Quality of Life*
Lymphoma, Non-Hodgkin/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lymphoma, Non-Hodgkin/therapy ; Male ; Middle Aged ; Reproducibility of Results ; Self Report ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
Autorzy:
Witzig TE; Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN 55905, USA. />Reeder CB
LaPlant BR
Gupta M
Johnston PB
Micallef IN
Porrata LF
Ansell SM
Colgan JP
Jacobsen ED
Ghobrial IM
Habermann TM
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2011 Feb; Vol. 25 (2), pp. 341-7. Date of Electronic Publication: 2010 Dec 07.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Non-Hodgkin/*drug therapy
Protein Kinase Inhibitors/*therapeutic use
Salvage Therapy/*methods
Sirolimus/*analogs & derivatives
TOR Serine-Threonine Kinases/*antagonists & inhibitors
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Everolimus ; Female ; Humans ; Lymphoma, Non-Hodgkin/complications ; Male ; Middle Aged ; Remission Induction ; Sirolimus/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
Autorzy:
Micallef IN; Divison of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. />Remstein ED
Ansell SM
Colgan JP
Inwards DJ
Johnston PB
Lewis JT
Markovic SN
Porrata LF
White WL
Witzig TE
Ristow K
Habermann TM
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2006 Sep; Vol. 47 (9), pp. 1794-9.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Transformation, Neoplastic/*pathology
Lymphoma, Large B-Cell, Diffuse/*pathology
Lymphoma, Non-Hodgkin/*pathology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Non-Hodgkin/drug therapy ; Male ; Middle Aged ; Prognosis ; Survival Rate
Czasopismo naukowe
Tytuł:
Clinical characteristics of familial vs. sporadic non-Hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000).
Autorzy:
Vachon CM; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. />Habermann TM
Kurtin PJ
Cerhan JR
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2004 May; Vol. 45 (5), pp. 929-35.
Typ publikacji:
Journal Article
MeSH Terms:
Family Health*
Lymphoma, Non-Hodgkin/*etiology
Adolescent ; Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Female ; Humans ; Leukemia ; Lymphoma ; Lymphoma, Non-Hodgkin/pathology ; Male ; Middle Aged ; Registries ; Retrospective Studies ; Sex Factors
Czasopismo naukowe
Tytuł:
Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
Autorzy:
Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Edwards WD
Macon WR
Habermann TM
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2001 Sep-Oct; Vol. 42 (5), pp. 1145-50.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenoviridae Infections/*chemically induced
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Liver Failure/*etiology
Lymphoma, Non-Hodgkin/*complications
Vidarabine/*analogs & derivatives
Vidarabine/*toxicity
Autopsy ; Fatal Outcome ; Humans ; Liver Failure/pathology ; Liver Failure/virology ; Lymphoma, Non-Hodgkin/drug therapy ; Male ; Middle Aged ; Vidarabine/administration & dosage
Czasopismo naukowe
Tytuł:
Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women.
Autorzy:
Parker AS; Department of Preventive Medicine and Environmental Health, The University of Iowa College of Medicine, Iowa City 52242, USA.
Cerhan JR
Dick F
Kemp J
Habermann TM
Wallace RB
Sellers TA
Folsom AR
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2000 Apr; Vol. 37 (3-4), pp. 341-9.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Lymphoma, Non-Hodgkin/*epidemiology
Smoking/*adverse effects
Age Factors ; Aged ; Cohort Studies ; Confounding Factors, Epidemiologic ; Female ; Follow-Up Studies ; Humans ; Iowa/epidemiology ; Lymphoma, Non-Hodgkin/pathology ; Middle Aged ; Risk Factors
Czasopismo naukowe
Tytuł:
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Autorzy:
Witzig TE; Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. />Camoriano JK
Schroeder G
Kurtin PJ
Habermann TM
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 1998 Jan; Vol. 28 (3-4), pp. 307-14.
Typ publikacji:
Clinical Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Granulocyte Colony-Stimulating Factor/*therapeutic use
Lymphoma, Non-Hodgkin/*drug therapy
Adult ; Age Factors ; Aged ; Ambulatory Care ; Bleomycin/therapeutic use ; Cyclophosphamide/therapeutic use ; Cytarabine/therapeutic use ; Doxorubicin/therapeutic use ; Drug Administration Schedule ; Etoposide/therapeutic use ; Female ; Humans ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Prednisone/therapeutic use ; Vincristine/therapeutic use
SCR Protocol:
PROMACE-CytaBOM protocol
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies